Suppr超能文献

小肠移植:当前进展与临床应用

Small bowel transplantation: current progress and clinical application.

作者信息

Frezza E E, Tzakis A, Fung J J, Van Thiel D H

机构信息

Pittsburgh Transplantation Institute, PA, USA.

出版信息

Hepatogastroenterology. 1996 Mar-Apr;43(8):363-76.

PMID:8714229
Abstract

Total parenteral nutrition (TPN) is used routinely to maintain patients with the Short Bowel Syndrome (SBS). Until recently, TPN has been the only available therapeutic modality for patients with SBS. Currently, it is the treatment of choice for such individuals and occasionally, when the loss of bowel is extensive, it may be the only way of maintaining life. Unfortunately, TPN is expensive and markedly restrains an individual's lifestyle. Despite the overall success of TPN, the numerous risks associated with its use and the many complications of having an intravenous indwelling for years have served as the stimulus for alternative treatments such as small bowel transplantation (SBT). The first attempts at small bowel transplantation in clinical medicine were by Detterling almost 25 years ago. Patient death or graft loss in these early attempts was caused by the failure to control graft rejection and/or the inability to prevent Graft Versus Host Disease (GVHD). A stimulus for renewed clinical interest in SBT was provided by Starzl et al in 1988 with a report of prolonged graft survival without graft rejection or GVHD in a patient who was the recipient of a multivisceral graft consisting of the entire small bowel and other abdominal organs. Since 1964, 78 Small Bowel transplants have been performed in humans. Several variations of the multivisceral procedure in which the liver and the small bowel constitute the major components of the graft were adopted. The longest survival has been in a child who is still alive with a working graft for more than two years, as reported by Goulet from Paris in 1989. The introduction in SBT of the new immunosuppressive agent FK 506 had provided results which are superior to those achieved with Cyclosporine A (CsA). This latter observation prompted the Pittsburgh group to initiate a large series of isolated and composite intestinal grafts. The remarkable results have demonstrated the clinical utility of intestinal transplantation. This paper will try to summarize the history of the small bowel transplantation until the end of the year 1992, with the current progress in use today.

摘要

全胃肠外营养(TPN)常用于维持短肠综合征(SBS)患者的营养。直到最近,TPN一直是SBS患者唯一可用的治疗方式。目前,它是这类患者的首选治疗方法,偶尔,当肠道损失广泛时,它可能是维持生命的唯一途径。不幸的是,TPN费用昂贵且严重限制个人生活方式。尽管TPN总体上取得了成功,但其使用相关的众多风险以及多年留置静脉导管的许多并发症促使人们寻求替代治疗方法,如小肠移植(SBT)。临床医学上首次尝试小肠移植是在大约25年前由Detterling进行的。这些早期尝试中患者死亡或移植物丢失是由于未能控制移植物排斥反应和/或无法预防移植物抗宿主病(GVHD)。1988年,Starzl等人报告了一名接受包含整个小肠和其他腹部器官的多脏器移植物的患者,移植物长期存活且无移植物排斥或GVHD,这重新激发了临床对SBT的兴趣。自1964年以来,已对人类进行了78例小肠移植。采用了几种多脏器手术的变体,其中肝脏和小肠构成移植物的主要成分。据巴黎的Goulet于1989年报道,存活时间最长的是一名儿童,其移植物功能良好已存活两年多。新型免疫抑制剂FK 506引入SBT后取得的结果优于环孢素A(CsA)。后一观察结果促使匹兹堡研究小组开展了一系列大量的孤立和复合肠道移植手术。显著的结果证明了肠道移植的临床实用性。本文将试图总结截至1992年底小肠移植的历史以及目前的应用进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验